BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Obesity, Heart, Early pregnancy factor, Ciprofibrate, rs3825942, DRD2, Apoptosis)
Bookmark Forward

QuickView for pipecolic acids (compound)


Genetic Markers

Most Correlated Genes

  1. SCN10A
  2. F2
  3. PTGER1
  4. ERG28
  5. ATXN1
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. clathrin coat
  2. YAGI_AML_WITH_T_9_11_TRANSLOCATION
  3. GSE11818_WT_VS_DICER_KO_TREG_UP
  4. regulation of response to wounding
  5. REACTOME_DIABETES_PATHWAYS
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Drug target sets for approved compounds
  2. Broad Connectivity Map (CMAP 2.0) compound database
  3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
  4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
  5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Enantioselective allylation of imines catalyzed by newly developed (-)-β-pinene-based π-allylpalladi…
  2. Pipecolic acid, an endogenous mediator of defense amplification and priming, is a critical regulator…
  3. Switching the stereochemical outcome of 6-endo-trig cyclizations; synthesis of 2,6-cis-6-substituted…
  4. An efficient lipase-catalyzed enantioselective hydrolysis of (R,S)-azolides derived from N-protected…
  5. Pipecolic acid derivatives as small-molecule inhibitors of the Legionella MIP protein.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Dietary Biomarkers 2.0: From Potential Towards Implementation.
  2. Evaluation of PDE MAX
  3. Peroxisomal Defects and Familial Risk for Bipolar Disorder
  4. Betaine and Peroxisome Biogenesis Disorders
  5. Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD)
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.